Study shows miR-22 plays a key role in both breast cancer and blood cancer

[News]

A mere 25 years ago, noncoding RNAs were considered nothing more than "background noise" in the overall genomic landscape. Now, two new studies reveal that one of these tiny noncoding molecules - microRNA-22 - plays an outsized role in two types of cancer.

More... (http://www.news-medical.net/news/20130704/Study-shows-miR-22-plays-a-key-role-in-both-breast-cancer-and-blood-cancer.aspx)